Harpoon Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES

Last updated:

Abstract:

Provided herein are immune cells engineered to express one or more cell surface receptor polypeptides containing activatable antigen receptor polypeptides, and methods of use thereof for the treatment of diseases, including cancer.

Status:
Application
Type:

Utility

Filling date:

3 May 2018

Issue date:

16 Apr 2020